S1052 A Nationwide Comparison of Ustekinumab, Vedolizumab, and Adalimumab on Infections, Vascular Disorders, and Neuromusculoskeletal Adverse Events in Ulcerative Colitis Patients: A Pharmacovigilance Investigation
American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S800-S800